john herr psychologist los gatos saratoga california

On Sabbatical

National Library of Medicine: IGM Full Record Screen

Help Log off IGM
Next Record Return to Results Return to Search Screen Previous Record




TITLE: Vasovagal syncope and skeletal muscle vasodilatation: the continuing conundrum.
AUTHOR: Dietz NM; Joyner MJ; Shepherd JT
AUTHOR AFFILIATION: Mayo Foundation, Rochester, Minnesota, USA.
SOURCE: Pacing Clin Electrophysiol 1997 Mar;20(3 Pt 2):775-80
NLM CIT. ID: 97235386
ABSTRACT: During vasovagal syncope, profound bradycardia and hypotension occur. Atropine administration can prevent the bradycardia but not the hypotension, suggesting that marked peripheral vasodilation is a major cause of the fall in arterial pressure. This concept has been confirmed since vasovagal syncope can be seen in patients who have undergone heart transplantation and also in patients subject to cardiac pacing. In both cases, there is no bradycardia but hypotension during the syncopal attacks. The major site of the vasodilation is in skeletal muscle and muscle sympathetic nerve activity is suppressed just prior to and during vasovagal attacks, indicating that sympathetic withdrawal contributes to the dilation. However, the skeletal muscle vasodilation seen during syncope is greater than that caused by sympathetic withdrawal alone, and it is absent in limbs that have undergone surgical sympathectomy, or local anesthetic nerve block. These observations suggest a role for neurally mediated "active" vasodilation during syncope. The afferent neural pathways that evoke the profound vasodilation during vasovagal attacks remain the subject of debate. The neural pathways responsible for the active component of the dilation are also unknown. Recent evidence has demonstrated that cholinergic, beta-adrenergic, and nitroxidergic (nitric oxide) vasodilator mechanisms are not essential to observe the dilation, demonstrating that the mechanisms responsible for it remain a continuing conundrum.
MAIN MESH SUBJECTS: Muscle, Skeletal/*BLOOD SUPPLY/INNERVATION
Syncope, Vasovagal/ETIOLOGY/*PHYSIOPATHOLOGY
Vasodilation/*PHYSIOLOGY
ADDITIONAL MESH SUBJECTS: Adrenergic Fibers/PHYSIOLOGY
Afferent Pathways/PHYSIOPATHOLOGY
Anti-Arrhythmia Agents/THERAPEUTIC USE
Atropine/THERAPEUTIC USE
Blood Pressure/PHYSIOLOGY
Bradycardia/COMPLICATIONS/PREVENTION & CONTROL
Cardiac Pacing, Artificial
Cholinergic Fibers/PHYSIOLOGY
Heart Transplantation/PHYSIOLOGY
Human
Hypotension/COMPLICATIONS
Nerve Block
Nitric Oxide/PHYSIOLOGY
Sympathectomy
Sympathetic Nervous System/PHYSIOPATHOLOGY
PUBLICATION TYPES: JOURNAL ARTICLE
REVIEW
REVIEW, TUTORIAL
LANGUAGE: Eng
REGISTRY NUMBERS: 0 (Anti-Arrhythmia Agents)
10102-43-9 (Nitric Oxide)
51-55-8 (Atropine)

Help Log off IGM
Next Record Return to Results Return to Search Screen Previous Record


On Sabbatical!

When my office lease expired at the end of 2004, I decided to turn it into a "sabbatical" from my private practice. Many years ago, in my grandfather's 89th year of life, he told me, "John, it is important to smell the roses while you can still smell them." His life gave living a very good reputation. It is also true that the pursuit of that philosophy required my grandfather to to re-open his assay office/ore market in Wickenburg, Arizona as a 75-year-old because he had run a little short of retirement money. Thus, if blessed with his luck and health, I'll be back.. --jjh

Copyright 1998-2007  John J. Herr, Ph.D.                                   Please send comments to jjherr@clinicalpsychologist.com